Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 10
Results: 15
Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1635, doi. 10.1007/s00262-018-2233-x
- By:
- Publication type:
- Article
Regulatory mechanisms of PD-L1 expression in cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1481, doi. 10.1007/s00262-018-2226-9
- By:
- Publication type:
- Article
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1647, doi. 10.1007/s00262-018-2223-z
- By:
- Publication type:
- Article
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1621, doi. 10.1007/s00262-018-2221-1
- By:
- Publication type:
- Article
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1589, doi. 10.1007/s00262-018-2220-2
- By:
- Publication type:
- Article
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1571, doi. 10.1007/s00262-018-2219-8
- By:
- Publication type:
- Article
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1533, doi. 10.1007/s00262-018-2201-5
- By:
- Publication type:
- Article
Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1559, doi. 10.1007/s00262-018-2218-9
- By:
- Publication type:
- Article
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1491, doi. 10.1007/s00262-018-2184-2
- By:
- Publication type:
- Article
3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E<sub>2</sub> are a promising alternative for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1611, doi. 10.1007/s00262-018-2216-y
- By:
- Publication type:
- Article
Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1579, doi. 10.1007/s00262-018-2212-2
- By:
- Publication type:
- Article
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1519, doi. 10.1007/s00262-018-2211-3
- By:
- Publication type:
- Article
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1505, doi. 10.1007/s00262-018-2198-9
- By:
- Publication type:
- Article
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T<sub>reg</sub> depletion.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1545, doi. 10.1007/s00262-018-2214-0
- By:
- Publication type:
- Article